{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:21Z","timestamp":1793400261840,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.forsciint.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T17:16:32Z","timestamp":1395854192000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"special_numbering":"C","title":["Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-2005","authenticated-orcid":false,"given":"Kazandra","family":"Ruiz-Col\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chavez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eric","family":"D\u00edaz-Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7111-9162","authenticated-orcid":false,"given":"Mar\u00eda A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0379-0738(03)00083-5","article-title":"A reported case involving impaired driving following self-administration of xylazine","volume":"134","author":"Stillwell","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0010","unstructured":"U.S. Food and Drug Administration, Animal & Veterinary, Animal Drugs@FDA http:\/\/www.accessdata.fda.gov\/scripts\/animaldrugsatfda\/."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jat\/25.4.245","article-title":"Severe intoxication with the veterinary tranquilizer xylazine in humans","volume":"25","author":"Hoffmann","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jemermed.2006.02.042","article-title":"Systemic toxicity after an ocular exposure to xylazine hydrochloride","volume":"30","author":"V\u00e9lez","year":"2006","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0195-5616(99)50058-2","article-title":"Alpha-2 agonists and antagonists","volume":"29","author":"Paddleford","year":"1999","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpba.2003.12.007","article-title":"Determination of xylazine and its metabolites by GC\u2013MS in equine urine for doping analysis","volume":"35","author":"Spyridaki","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine-a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.forsciint.2014.03.015_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/15563658108990293","article-title":"Human xylazine overdose: a comparative review of clonidine","volume":"18","author":"Gallanosa","year":"1981","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.forsciint.2014.03.015_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","article-title":"The pharmacokinetics of xylazine hydrochloride: an interspecific study","volume":"4","author":"Garcia-Villar","year":"1981","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/15563657908989878","article-title":"Xylazine hydrochloridine (Rompun) overdose in man","volume":"15","author":"Carruthers","year":"1979","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0055","first-page":"145","article-title":"Chemical studies to detect residues of xylazine hydrochloride","volume":"73","author":"Putter","year":"1973","journal-title":"Vet. Med. Rev."},{"issue":"6","key":"10.1016\/j.forsciint.2014.03.015_bib0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0090-9556(25)08804-X","article-title":"Characterization of metabolites of xylazine produced in vivo and in vitro by LC\/MS\/MS and by GC\/MS","volume":"20","author":"Mutlib","year":"1992","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.forsciint.2014.03.015_bib0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bmc.2875","article-title":"Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry","volume":"27","author":"Lavoie","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"30","key":"10.1016\/j.forsciint.2014.03.015_bib0070","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","article-title":"Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR\u2013MSn","volume":"405","author":"Meyer","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst. Abuse Treat Prev. Policy"},{"issue":"5","key":"10.1016\/j.forsciint.2014.03.015_bib0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jat\/bks024","article-title":"Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC\u2013MS\u2013MS","volume":"36","author":"Ruiz-Col\u00f3n","year":"2012","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC\u2013MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.forsciint.2014.03.015_bib0090","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/j.1360-0443.1996.tb03800.x","article-title":"Fatal heroin \u2018overdose\u2019: a review","volume":"91","author":"Darke","year":"1996","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0095","first-page":"197","article-title":"Heroin, part III: the pharmacology of heroin","volume":"73","author":"Hosztafi","year":"2003","journal-title":"Acta Pharm. Hung."},{"issue":"2","key":"10.1016\/j.forsciint.2014.03.015_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/en2007.05.15.2.30.c4243","article-title":"Managing acute heroin overdose","volume":"15","author":"Dixon","year":"2007","journal-title":"Emerg. Nurse"},{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/brb3.7","article-title":"Epidemic of illicit drug use, mechanisms of action\/addiction and stroke as a health hazard","volume":"1","author":"Esse","year":"2011","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/2229-5151.124161","article-title":"Use of dexmedetomidine to facilitate non-invasive ventilation","volume":"3","author":"Demuro","year":"2013","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0735-6757(86)90070-7","article-title":"Human overdose with the veterinary tranquilizer xylazine","volume":"4","author":"Spoerke","year":"1986","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/bmj.287.6402.1369","article-title":"Clinical curio: self-medication with xylazine","volume":"287","author":"Lewis","year":"1983","journal-title":"Br. Med. J."},{"issue":"10","key":"10.1016\/j.forsciint.2014.03.015_bib0125","first-page":"782","article-title":"Misuse of xylazine","volume":"29","author":"Haigh","year":"1988","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/pgmj.66.773.244","article-title":"Accidental self administration of xylazine in a veterinary nurse","volume":"66","author":"Samanta","year":"1990","journal-title":"Postgrad. Med. J."},{"issue":"6","key":"10.1016\/j.forsciint.2014.03.015_bib0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","article-title":"Severe intoxication from xylazine inhalation","volume":"17","author":"Capraro","year":"2001","journal-title":"Pediatr. Emerg. Care"},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00063110-200309000-00022","article-title":"Drug abuse with inhalated xylazine","volume":"10","author":"Elejalde","year":"2003","journal-title":"Eur. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.forsciint.2014.03.015_bib0145","first-page":"324","article-title":"An unusual presentation from xylazine-ketamine","volume":"46","author":"Arican","year":"2004","journal-title":"Vet. Hum. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jat\/31.3.165","article-title":"Solid-phase extraction and gas chromatographic\u2013mass spectrometric determination of the veterinary drug xylazine in human blood","volume":"31","author":"Barroso","year":"2007","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/15563650601073520","article-title":"Xylazine abuse: a rare cause of syncope","volume":"45","author":"Liu","year":"2007","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"9\u201310","key":"10.1016\/j.forsciint.2014.03.015_bib0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/dta.1475","article-title":"Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC\u2013MS and LC\u2013MS","volume":"5","author":"Meyer","year":"2013","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.forsciint.2014.03.015_bib0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office","volume":"53","author":"Wong","year":"2008","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0170","series-title":"Forensic Toxicology Proceedings 2002\u20132011","first-page":"77 pp","article-title":"Nine xylazine related deaths in Puerto Rico, oral presentation (K44)","author":"Chavez","year":"2009"},{"key":"10.1016\/j.forsciint.2014.03.015_bib0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jat\/9.5.234","article-title":"Xylazine in human tissues and fluids in a case of fatal drug abuse","volume":"9","author":"Poklis","year":"1985","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0180","first-page":"28","article-title":"A fatal intoxication with xylazine","volume":"24","author":"Briellmann","year":"1994","journal-title":"TIAFT Bull. Case Notes"},{"key":"10.1016\/j.forsciint.2014.03.015_bib0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1520\/JFS16155J","article-title":"Xylazine toxicity-literature review and report of two cases","volume":"43","author":"Mittleman","year":"1998","journal-title":"J. Forensic Sci."},{"issue":"2","key":"10.1016\/j.forsciint.2014.03.015_bib0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jat\/27.2.110","article-title":"Tissue distribution of xylazine in a suicide by hanging","volume":"27","author":"Moore","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2014.03.015_bib0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.forsciint.2014.03.015_bib0200","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2008"},{"key":"10.1016\/j.forsciint.2014.03.015_bib0205","series-title":"Goodman and Gilmans's, Manual of Pharmacology and Therapeutics","author":"Bruton","year":"2008"},{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.forsciint.2014.03.015_bib0215","first-page":"171","article-title":"Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, Marijuana, Heroin, Cocaine, and Caffeine","volume":"13","author":"Fitzgerald","year":"2013","journal-title":"Subst. Abuse"},{"issue":"11","key":"10.1016\/j.forsciint.2014.03.015_bib0220","first-page":"317","article-title":"Xylazine-morphine sequence to obtain analgesia in the horse and dog","volume":"18","author":"Huska","year":"1977","journal-title":"Can. Vet. J."},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2460\/ajvr.2004.65.519","article-title":"Influence of morphine sulfate on the halothane sparing effect of xylazine hydrochloride in horses","volume":"65","author":"Bennett","year":"2004","journal-title":"Am. J. Vet. Res."},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2460\/ajvr.1995.56.04.496","article-title":"Cardiovascular effects of epidurally administered morphine and a xylazine-morphine combination in isoflurane-anesthetized dogs","volume":"56","author":"Keegan","year":"1995","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.forsciint.2014.03.015_bib0235","series-title":"Principles of Forensic Toxicology","first-page":"247","author":"Levine","year":"2010"},{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.forsciint.2014.03.015_bib0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/00952990.2011.643997","article-title":"Drug interactions between common illicit drugs and prescription therapies","volume":"38","author":"Lindsey","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.forsciint.2014.03.015_bib0250","first-page":"103","article-title":"Effect of cocaine on xylazine analgesic activity","volume":"21","author":"Leonhardt","year":"1988","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"11","key":"10.1016\/j.forsciint.2014.03.015_bib0255","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1360-0443.2007.01969.x","article-title":"Crack-heroin speedball injection and its implications for vein care: qualitative study","volume":"102","author":"Rhodes","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2014.03.015_bib0260","series-title":"American College of Medical Toxicology Annual Scientific Meeting in San Juan, Puerto Rico","article-title":"Prevalence of xylazine in postmortem cases related to heroin and\/or cocaine intoxication","author":"Ruiz","year":"2013"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:59:32Z","timestamp":1746161972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073814001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":52,"alternative-id":["S0379073814001170"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.03.015","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}